1 Introduction to Research & Analysis Reports
    1.1 Ophthalmology Disorders Drug Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Ophthalmology Disorders Drug Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Ophthalmology Disorders Drug Overall Market Size
    2.1 Global Ophthalmology Disorders Drug Market Size: 2021 VS 2028
    2.2 Global Ophthalmology Disorders Drug Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Ophthalmology Disorders Drug Players in Global Market
    3.2 Top Global Ophthalmology Disorders Drug Companies Ranked by Revenue
    3.3 Global Ophthalmology Disorders Drug Revenue by Companies
    3.4 Top 3 and Top 5 Ophthalmology Disorders Drug Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Ophthalmology Disorders Drug Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Ophthalmology Disorders Drug Players in Global Market
        3.6.1 List of Global Tier 1 Ophthalmology Disorders Drug Companies
        3.6.2 List of Global Tier 2 and Tier 3 Ophthalmology Disorders Drug Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Ophthalmology Disorders Drug Market Size Markets, 2021 & 2028
        4.1.2 Oral
        4.1.3 Injection
        4.1.4 External Use
    4.2 By Type - Global Ophthalmology Disorders Drug Revenue & Forecasts
        4.2.1 By Type - Global Ophthalmology Disorders Drug Revenue, 2017-2022
        4.2.2 By Type - Global Ophthalmology Disorders Drug Revenue, 2023-2028
        4.2.3 By Type - Global Ophthalmology Disorders Drug Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Ophthalmology Disorders Drug Market Size, 2021 & 2028
        5.1.2 Juvenile Macular Degeneration (Stargardt Disease)
        5.1.3 Leber Congenital Amaurosis (LCA)
        5.1.4 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy)
        5.1.5 Usher Syndrome
        5.1.6 Retinitis Pigmentosa (Retinitis)
    5.2 By Application - Global Ophthalmology Disorders Drug Revenue & Forecasts
        5.2.1 By Application - Global Ophthalmology Disorders Drug Revenue, 2017-2022
        5.2.2 By Application - Global Ophthalmology Disorders Drug Revenue, 2023-2028
        5.2.3 By Application - Global Ophthalmology Disorders Drug Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Ophthalmology Disorders Drug Market Size, 2021 & 2028
    6.2 By Region - Global Ophthalmology Disorders Drug Revenue & Forecasts
        6.2.1 By Region - Global Ophthalmology Disorders Drug Revenue, 2017-2022
        6.2.2 By Region - Global Ophthalmology Disorders Drug Revenue, 2023-2028
        6.2.3 By Region - Global Ophthalmology Disorders Drug Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Ophthalmology Disorders Drug Revenue, 2017-2028
        6.3.2 US Ophthalmology Disorders Drug Market Size, 2017-2028
        6.3.3 Canada Ophthalmology Disorders Drug Market Size, 2017-2028
        6.3.4 Mexico Ophthalmology Disorders Drug Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Ophthalmology Disorders Drug Revenue, 2017-2028
        6.4.2 Germany Ophthalmology Disorders Drug Market Size, 2017-2028
        6.4.3 France Ophthalmology Disorders Drug Market Size, 2017-2028
        6.4.4 U.K. Ophthalmology Disorders Drug Market Size, 2017-2028
        6.4.5 Italy Ophthalmology Disorders Drug Market Size, 2017-2028
        6.4.6 Russia Ophthalmology Disorders Drug Market Size, 2017-2028
        6.4.7 Nordic Countries Ophthalmology Disorders Drug Market Size, 2017-2028
        6.4.8 Benelux Ophthalmology Disorders Drug Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Ophthalmology Disorders Drug Revenue, 2017-2028
        6.5.2 China Ophthalmology Disorders Drug Market Size, 2017-2028
        6.5.3 Japan Ophthalmology Disorders Drug Market Size, 2017-2028
        6.5.4 South Korea Ophthalmology Disorders Drug Market Size, 2017-2028
        6.5.5 Southeast Asia Ophthalmology Disorders Drug Market Size, 2017-2028
        6.5.6 India Ophthalmology Disorders Drug Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Ophthalmology Disorders Drug Revenue, 2017-2028
        6.6.2 Brazil Ophthalmology Disorders Drug Market Size, 2017-2028
        6.6.3 Argentina Ophthalmology Disorders Drug Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Ophthalmology Disorders Drug Revenue, 2017-2028
        6.7.2 Turkey Ophthalmology Disorders Drug Market Size, 2017-2028
        6.7.3 Israel Ophthalmology Disorders Drug Market Size, 2017-2028
        6.7.4 Saudi Arabia Ophthalmology Disorders Drug Market Size, 2017-2028
        6.7.5 UAE Ophthalmology Disorders Drug Market Size, 2017-2028
7 Players Profiles
    7.1 Sanofi
        7.1.1 Sanofi Corporate Summary
        7.1.2 Sanofi Business Overview
        7.1.3 Sanofi Ophthalmology Disorders Drug Major Product Offerings
        7.1.4 Sanofi Ophthalmology Disorders Drug Revenue in Global Market (2017-2022)
        7.1.5 Sanofi Key News
    7.2 Bayer
        7.2.1 Bayer Corporate Summary
        7.2.2 Bayer Business Overview
        7.2.3 Bayer Ophthalmology Disorders Drug Major Product Offerings
        7.2.4 Bayer Ophthalmology Disorders Drug Revenue in Global Market (2017-2022)
        7.2.5 Bayer Key News
    7.3 Bausch + Lomb
        7.3.1 Bausch + Lomb Corporate Summary
        7.3.2 Bausch + Lomb Business Overview
        7.3.3 Bausch + Lomb Ophthalmology Disorders Drug Major Product Offerings
        7.3.4 Bausch + Lomb Ophthalmology Disorders Drug Revenue in Global Market (2017-2022)
        7.3.5 Bausch + Lomb Key News
    7.4 Novartis
        7.4.1 Novartis Corporate Summary
        7.4.2 Novartis Business Overview
        7.4.3 Novartis Ophthalmology Disorders Drug Major Product Offerings
        7.4.4 Novartis Ophthalmology Disorders Drug Revenue in Global Market (2017-2022)
        7.4.5 Novartis Key News
    7.5 Usher Syndrome
        7.5.1 Usher Syndrome Corporate Summary
        7.5.2 Usher Syndrome Business Overview
        7.5.3 Usher Syndrome Ophthalmology Disorders Drug Major Product Offerings
        7.5.4 Usher Syndrome Ophthalmology Disorders Drug Revenue in Global Market (2017-2022)
        7.5.5 Usher Syndrome Key News
    7.6 Takeda Pharmaceutical
        7.6.1 Takeda Pharmaceutical Corporate Summary
        7.6.2 Takeda Pharmaceutical Business Overview
        7.6.3 Takeda Pharmaceutical Ophthalmology Disorders Drug Major Product Offerings
        7.6.4 Takeda Pharmaceutical Ophthalmology Disorders Drug Revenue in Global Market (2017-2022)
        7.6.5 Takeda Pharmaceutical Key News
    7.7 Roche
        7.7.1 Roche Corporate Summary
        7.7.2 Roche Business Overview
        7.7.3 Roche Ophthalmology Disorders Drug Major Product Offerings
        7.7.4 Roche Ophthalmology Disorders Drug Revenue in Global Market (2017-2022)
        7.7.5 Roche Key News
    7.8 Pfizer
        7.8.1 Pfizer Corporate Summary
        7.8.2 Pfizer Business Overview
        7.8.3 Pfizer Ophthalmology Disorders Drug Major Product Offerings
        7.8.4 Pfizer Ophthalmology Disorders Drug Revenue in Global Market (2017-2022)
        7.8.5 Pfizer Key News
    7.9 Allergan
        7.9.1 Allergan Corporate Summary
        7.9.2 Allergan Business Overview
        7.9.3 Allergan Ophthalmology Disorders Drug Major Product Offerings
        7.9.4 Allergan Ophthalmology Disorders Drug Revenue in Global Market (2017-2022)
        7.9.5 Allergan Key News
    7.10 Gilead Sciences
        7.10.1 Gilead Sciences Corporate Summary
        7.10.2 Gilead Sciences Business Overview
        7.10.3 Gilead Sciences Ophthalmology Disorders Drug Major Product Offerings
        7.10.4 Gilead Sciences Ophthalmology Disorders Drug Revenue in Global Market (2017-2022)
        7.10.5 Gilead Sciences Key News
    7.11 Kubota Pharmaceutical
        7.11.1 Kubota Pharmaceutical Corporate Summary
        7.11.2 Kubota Pharmaceutical Business Overview
        7.11.3 Kubota Pharmaceutical Ophthalmology Disorders Drug Major Product Offerings
        7.11.4 Kubota Pharmaceutical Ophthalmology Disorders Drug Revenue in Global Market (2017-2022)
        7.11.5 Kubota Pharmaceutical Key News
    7.12 Alkeus Pharmaceuticals
        7.12.1 Alkeus Pharmaceuticals Corporate Summary
        7.12.2 Alkeus Pharmaceuticals Business Overview
        7.12.3 Alkeus Pharmaceuticals Ophthalmology Disorders Drug Major Product Offerings
        7.12.4 Alkeus Pharmaceuticals Ophthalmology Disorders Drug Revenue in Global Market (2017-2022)
        7.12.5 Alkeus Pharmaceuticals Key News
    7.13 Astellas Pharma
        7.13.1 Astellas Pharma Corporate Summary
        7.13.2 Astellas Pharma Business Overview
        7.13.3 Astellas Pharma Ophthalmology Disorders Drug Major Product Offerings
        7.13.4 Astellas Pharma Ophthalmology Disorders Drug Revenue in Global Market (2017-2022)
        7.13.5 Astellas Pharma Key News
    7.14 Ferrer Corporate
        7.14.1 Ferrer Corporate Corporate Summary
        7.14.2 Ferrer Corporate Business Overview
        7.14.3 Ferrer Corporate Ophthalmology Disorders Drug Major Product Offerings
        7.14.4 Ferrer Corporate Ophthalmology Disorders Drug Revenue in Global Market (2017-2022)
        7.14.5 Ferrer Corporate Key News
    7.15 Amgen Inc
        7.15.1 Amgen Inc Corporate Summary
        7.15.2 Amgen Inc Business Overview
        7.15.3 Amgen Inc Ophthalmology Disorders Drug Major Product Offerings
        7.15.4 Amgen Inc Ophthalmology Disorders Drug Revenue in Global Market (2017-2022)
        7.15.5 Amgen Inc Key News
    7.16 Editas Medicine Inc
        7.16.1 Editas Medicine Inc Corporate Summary
        7.16.2 Editas Medicine Inc Business Overview
        7.16.3 Editas Medicine Inc Ophthalmology Disorders Drug Major Product Offerings
        7.16.4 Editas Medicine Inc Ophthalmology Disorders Drug Revenue in Global Market (2017-2022)
        7.16.5 Editas Medicine Inc Key News
    7.17 ProQR Therapeutics NV
        7.17.1 ProQR Therapeutics NV Corporate Summary
        7.17.2 ProQR Therapeutics NV Business Overview
        7.17.3 ProQR Therapeutics NV Ophthalmology Disorders Drug Major Product Offerings
        7.17.4 ProQR Therapeutics NV Ophthalmology Disorders Drug Revenue in Global Market (2017-2022)
        7.17.5 ProQR Therapeutics NV Key News
    7.18 ReNeuron
        7.18.1 ReNeuron Corporate Summary
        7.18.2 ReNeuron Business Overview
        7.18.3 ReNeuron Ophthalmology Disorders Drug Major Product Offerings
        7.18.4 ReNeuron Ophthalmology Disorders Drug Revenue in Global Market (2017-2022)
        7.18.5 ReNeuron Key News
    7.19 Amarantus BioScience
        7.19.1 Amarantus BioScience Corporate Summary
        7.19.2 Amarantus BioScience Business Overview
        7.19.3 Amarantus BioScience Ophthalmology Disorders Drug Major Product Offerings
        7.19.4 Amarantus BioScience Ophthalmology Disorders Drug Revenue in Global Market (2017-2022)
        7.19.5 Amarantus BioScience Key News
    7.20 Ocugen
        7.20.1 Ocugen Corporate Summary
        7.20.2 Ocugen Business Overview
        7.20.3 Ocugen Ophthalmology Disorders Drug Major Product Offerings
        7.20.4 Ocugen Ophthalmology Disorders Drug Revenue in Global Market (2017-2022)
        7.20.5 Ocugen Key News
    7.21 ReGenX Biosciences
        7.21.1 ReGenX Biosciences Corporate Summary
        7.21.2 ReGenX Biosciences Business Overview
        7.21.3 ReGenX Biosciences Ophthalmology Disorders Drug Major Product Offerings
        7.21.4 ReGenX Biosciences Ophthalmology Disorders Drug Revenue in Global Market (2017-2022)
        7.21.5 ReGenX Biosciences Key News
    7.22 Sucampo Pharmaceuticals
        7.22.1 Sucampo Pharmaceuticals Corporate Summary
        7.22.2 Sucampo Pharmaceuticals Business Overview
        7.22.3 Sucampo Pharmaceuticals Ophthalmology Disorders Drug Major Product Offerings
        7.22.4 Sucampo Pharmaceuticals Ophthalmology Disorders Drug Revenue in Global Market (2017-2022)
        7.22.5 Sucampo Pharmaceuticals Key News
    7.23 Orphagen Pharmaceuticals
        7.23.1 Orphagen Pharmaceuticals Corporate Summary
        7.23.2 Orphagen Pharmaceuticals Business Overview
        7.23.3 Orphagen Pharmaceuticals Ophthalmology Disorders Drug Major Product Offerings
        7.23.4 Orphagen Pharmaceuticals Ophthalmology Disorders Drug Revenue in Global Market (2017-2022)
        7.23.5 Orphagen Pharmaceuticals Key News
    7.24 Okuvision
        7.24.1 Okuvision Corporate Summary
        7.24.2 Okuvision Business Overview
        7.24.3 Okuvision Ophthalmology Disorders Drug Major Product Offerings
        7.24.4 Okuvision Ophthalmology Disorders Drug Revenue in Global Market (2017-2022)
        7.24.5 Okuvision Key News
    7.25 Second Sight Medical
        7.25.1 Second Sight Medical Corporate Summary
        7.25.2 Second Sight Medical Business Overview
        7.25.3 Second Sight Medical Ophthalmology Disorders Drug Major Product Offerings
        7.25.4 Second Sight Medical Ophthalmology Disorders Drug Revenue in Global Market (2017-2022)
        7.25.5 Second Sight Medical Key News
    7.26 Acucela
        7.26.1 Acucela Corporate Summary
        7.26.2 Acucela Business Overview
        7.26.3 Acucela Ophthalmology Disorders Drug Major Product Offerings
        7.26.4 Acucela Ophthalmology Disorders Drug Revenue in Global Market (2017-2022)
        7.26.5 Acucela Key News
    7.27 Stealth BioTherapeutics
        7.27.1 Stealth BioTherapeutics Corporate Summary
        7.27.2 Stealth BioTherapeutics Business Overview
        7.27.3 Stealth BioTherapeutics Ophthalmology Disorders Drug Major Product Offerings
        7.27.4 Stealth BioTherapeutics Ophthalmology Disorders Drug Revenue in Global Market (2017-2022)
        7.27.5 Stealth BioTherapeutics Key News
    7.28 Sun Pharma Advanced Research Company
        7.28.1 Sun Pharma Advanced Research Company Corporate Summary
        7.28.2 Sun Pharma Advanced Research Company Business Overview
        7.28.3 Sun Pharma Advanced Research Company Ophthalmology Disorders Drug Major Product Offerings
        7.28.4 Sun Pharma Advanced Research Company Ophthalmology Disorders Drug Revenue in Global Market (2017-2022)
        7.28.5 Sun Pharma Advanced Research Company Key News
    7.29 AmpliPhi Biosciences
        7.29.1 AmpliPhi Biosciences Corporate Summary
        7.29.2 AmpliPhi Biosciences Business Overview
        7.29.3 AmpliPhi Biosciences Ophthalmology Disorders Drug Major Product Offerings
        7.29.4 AmpliPhi Biosciences Ophthalmology Disorders Drug Revenue in Global Market (2017-2022)
        7.29.5 AmpliPhi Biosciences Key News
    7.30 Applied Genetic Technologies
        7.30.1 Applied Genetic Technologies Corporate Summary
        7.30.2 Applied Genetic Technologies Business Overview
        7.30.3 Applied Genetic Technologies Ophthalmology Disorders Drug Major Product Offerings
        7.30.4 Applied Genetic Technologies Ophthalmology Disorders Drug Revenue in Global Market (2017-2022)
        7.30.5 Applied Genetic Technologies Key News
    7.31 Asklepios BioPharmaceutical
        7.31.1 Asklepios BioPharmaceutical Corporate Summary
        7.31.2 Asklepios BioPharmaceutical Business Overview
        7.31.3 Asklepios BioPharmaceutical Ophthalmology Disorders Drug Major Product Offerings
        7.31.4 Asklepios BioPharmaceutical Ophthalmology Disorders Drug Revenue in Global Market (2017-2022)
        7.31.5 Asklepios BioPharmaceutical Key News
    7.32 Biovista
        7.32.1 Biovista Corporate Summary
        7.32.2 Biovista Business Overview
        7.32.3 Biovista Ophthalmology Disorders Drug Major Product Offerings
        7.32.4 Biovista Ophthalmology Disorders Drug Revenue in Global Market (2017-2022)
        7.32.5 Biovista Key News
    7.33 Spark Therapeutics
        7.33.1 Spark Therapeutics Corporate Summary
        7.33.2 Spark Therapeutics Business Overview
        7.33.3 Spark Therapeutics Ophthalmology Disorders Drug Major Product Offerings
        7.33.4 Spark Therapeutics Ophthalmology Disorders Drug Revenue in Global Market (2017-2022)
        7.33.5 Spark Therapeutics Key News
    7.34 Caladrius Biosciences
        7.34.1 Caladrius Biosciences Corporate Summary
        7.34.2 Caladrius Biosciences Business Overview
        7.34.3 Caladrius Biosciences Ophthalmology Disorders Drug Major Product Offerings
        7.34.4 Caladrius Biosciences Ophthalmology Disorders Drug Revenue in Global Market (2017-2022)
        7.34.5 Caladrius Biosciences Key News
    7.35 Dompe Farmaceutici
        7.35.1 Dompe Farmaceutici Corporate Summary
        7.35.2 Dompe Farmaceutici Business Overview
        7.35.3 Dompe Farmaceutici Ophthalmology Disorders Drug Major Product Offerings
        7.35.4 Dompe Farmaceutici Ophthalmology Disorders Drug Revenue in Global Market (2017-2022)
        7.35.5 Dompe Farmaceutici Key News
    7.36 Dormant Projects
        7.36.1 Dormant Projects Corporate Summary
        7.36.2 Dormant Projects Business Overview
        7.36.3 Dormant Projects Ophthalmology Disorders Drug Major Product Offerings
        7.36.4 Dormant Projects Ophthalmology Disorders Drug Revenue in Global Market (2017-2022)
        7.36.5 Dormant Projects Key News
    7.37 Grupo Ferrer Internacional
        7.37.1 Grupo Ferrer Internacional Corporate Summary
        7.37.2 Grupo Ferrer Internacional Business Overview
        7.37.3 Grupo Ferrer Internacional Ophthalmology Disorders Drug Major Product Offerings
        7.37.4 Grupo Ferrer Internacional Ophthalmology Disorders Drug Revenue in Global Market (2017-2022)
        7.37.5 Grupo Ferrer Internacional Key News
    7.38 ID Pharma
        7.38.1 ID Pharma Corporate Summary
        7.38.2 ID Pharma Business Overview
        7.38.3 ID Pharma Ophthalmology Disorders Drug Major Product Offerings
        7.38.4 ID Pharma Ophthalmology Disorders Drug Revenue in Global Market (2017-2022)
        7.38.5 ID Pharma Key News
    7.39 InFlectis BioScience
        7.39.1 InFlectis BioScience Corporate Summary
        7.39.2 InFlectis BioScience Business Overview
        7.39.3 InFlectis BioScience Ophthalmology Disorders Drug Major Product Offerings
        7.39.4 InFlectis BioScience Ophthalmology Disorders Drug Revenue in Global Market (2017-2022)
        7.39.5 InFlectis BioScience Key News
    7.40 Ionis Pharmaceuticals
        7.40.1 Ionis Pharmaceuticals Corporate Summary
        7.40.2 Ionis Pharmaceuticals Business Overview
        7.40.3 Ionis Pharmaceuticals Ophthalmology Disorders Drug Major Product Offerings
        7.40.4 Ionis Pharmaceuticals Ophthalmology Disorders Drug Revenue in Global Market (2017-2022)
        7.40.5 Ionis Pharmaceuticals Key News
    7.41 Ixchel Pharma
    7.42 Khondrion
    7.43 Mimetogen Pharmaceuticals
    7.44 Mitotech
    7.45 M's Science
    7.46 Nanovector
    7.47 SanBio
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer